Anxiety Disorders and Depression Treatment Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2015-2020 and Forecast 2021-2027

$ PRICE - $ 3,000.00$ 8,900.00

Global Anxiety Disorders and Depression Treatment Market By Product Type (MAOIs (Monoamine Oxidase inhibitors), Atypical Antipsychotics, Benzodiazepines, Anticonvulsants, Beta-Blockers, SRIs (Selective Serotonin Reuptake Inhibitors), SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors), TeCAs (Tetracyclic Antidepressants), TCAs (Tricyclic Antidepressants), Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Others), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The global Anxiety Disorders and Depression Treatment Market size was estimated at USD 8.2 Bn in 2021, growing at a CAGR of 27.8% during the forecast period 2021-2027. Anxiety is a disorder that differs from normal feelings of nervousness or anxiousness. It involves excessive anxiety. Anxiety is a normal reaction to stress. For a patient with anxiety disorder, the anxiety does not lessen but can get worse over a period of time. As per the American Psychiatric Association, Anxiety disorders are the most common of mental disorders and affect nearly 30 percent of adults at some point in their lives. The feelings can interfere with daily activities. There are various kinds of anxiety disorders such as social anxiety disorder and panic disorder. The Anxiety Disorders and Depression Treatment Market research report covers exhaustive regional information, that includes North America (the USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland, and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentian, Venezuela, and Rest of Latin America), and the Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of the Middle East and Africa).


Anxiety Disorders and Depression Treatment Market

MARKET SUMMARY
-
27.8% CAGR
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– 27.8%
  • Largest Market– North America
  • Fastest Growing Market– APAC

Anxiety Disorders and Depression Treatment Market

  • The report on the global Anxiety Disorders and Depression Treatment Market gives historical, current, and future market sizes (US$ Bn) based on the product type, distribution channel, and Geography.
  • Global Anxiety Disorders and Depression Treatment Market gives a comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and the Middle East, and Africa.
Market Key Players
  • MAOIs (Monoamine Oxidase inhibitors)
  • Atypical Antipsychotics
  • Benzodiazepines
  • Anticonvulsants
  • Beta-Blockers
  • SRIs (Selective Serotonin Reuptake Inhibitors)
Drivers And Restraints

Anxiety Disorders and Depression Treatment Market

Increase in the prevalence of anxiety disorder and depression is majorly driving the growth of the anxiety disorders and depression treatment market. According to the World Health Organization (WHO), in 2017, over 300 million people of all ages globally are suffering from depression, wherein 800,000 people die due to suicide, of which, anxiety disorders and depression are a prime cause. The rising demand for the antidepressants can be attributed to the growth of the market. Growing geriatric population along with mental disorders are adding fuel for the growth of the anxiety disorders and depression treatment market. However, the factors such as patent expiry of the drugs and adoption of the other treatment options such as herbal treatment are expected to hinder the growth of the market. The growing generic drugs are likely to restrain the growth of the anxiety disorders and depression treatment market.


North-America got significant share

Anxiety Disorders and Depression Treatment Market

Geographically, global anxiety disorders and depression treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North Americaanxiety disorders and depression treatment market is the dominant market when compared with that of the other regional markets. According to the National Alliance on Mental Illness, Anxiety disorders are the most common mental health concern in the United States. An estimated 40 million adults in the United States (18%) have an anxiety disorder. Meanwhile, approximately 8% of children and teenagers experience an anxiety disorder. Most people develop symptoms before age 21. According to the Mental Health America, in 2014, 1 in every 5 adults have a mental health condition and the condition is observed to be worsening at rapid rates in youth. The Asia Pacific anxiety disorders and depression treatment market is expected to show a luxurious growth over the forecasted period.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market and forecast
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Segmentation

Anxiety Disorders and Depression Treatment Market


Location

GEOGRAPHY


Report

Table Of Content

Table of Content

  1. Executive Summary
  2. Global Anxiety Disorders and Depression Treatment Market Introduction
    • Global Anxiety Disorders and Depression Treatment Market – Taxonomy
    • Global Anxiety Disorders and Depression Treatment Market –Definitions
      • Product Type
      • Distribution Channel
  1. Global Anxiety Disorders and Depression Treatment Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Anxiety Disorders and Depression Treatment Market Dynamic Factors – Impact Analysis
    • Global Anxiety Disorders and Depression Treatment Market – Competition Landscape
    • Epidemiology
  2. Global Anxiety Disorders and Depression Treatment Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026
    • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market OpportunityAnalysis
  3. Global Anxiety Disorders and Depression Treatment Market, By Product Type, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • MAOIs (Monoamine Oxidase inhibitors)
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Atypical Antipsychotics
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Benzodiazepines
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Anticonvulsants
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Beta-Blockers
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • SRIs (Selective Serotonin Reuptake Inhibitors)
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • TeCAs (Tetracyclic Antidepressants)
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • TCAs (Tricyclic Antidepressants)
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Anxiety Disorders and Depression Treatment Market Forecast, By Distribution Channel, 2015 – 2019 and Forecast, 2020 – 2026
    • Hospital Pharmacies
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Online Pharmacies
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Anxiety Disorders and Depression Treatment Market Forecast, By Region, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Anxiety Disorders and Depression Treatment Market – Opportunity Analysis Index, By Product Type, By Distribution Channel and Region, 2020 – 2026
  2. North America Anxiety Disorders and Depression Treatment MarketAnalysis,2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Product Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • MAOIs (Monoamine Oxidase inhibitors)
      • Atypical Antipsychotics
      • Benzodiazepines
      • Anticonvulsants
      • Beta-Blockers
      • SRIs (Selective Serotonin Reuptake Inhibitors)
      • SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)
      • TeCAs (Tetracyclic Antidepressants)
      • TCAs (Tricyclic Antidepressants)
      • Others
    • Distribution Channel Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Online Pharmacies
      • Others
    • Country Analysis 2016 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • US
      • Canada
    • North America Anxiety Disorders and Depression Treatment Market – Opportunity Analysis Index, By Product Type, By Distribution Channel and Country, 2020 – 2026
    • North America Anxiety Disorders and Depression Treatment Market Dynamics – Trends
  3. Europe Anxiety Disorders and Depression Treatment Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Product Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • MAOIs (Monoamine Oxidase inhibitors)
      • Atypical Antipsychotics
      • Benzodiazepines
      • Anticonvulsants
      • Beta-Blockers
      • SRIs (Selective Serotonin Reuptake Inhibitors)
      • SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)
      • TeCAs (Tetracyclic Antidepressants)
      • TCAs (Tricyclic Antidepressants)
      • Others
    • Distribution Channel Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Online Pharmacies
      • Others
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Anxiety Disorders and Depression Treatment Market – Opportunity Analysis Index, By Product Type, By Distribution Channel, and Country,2020 – 2026
    • Europe Anxiety Disorders and Depression Treatment Market Dynamics – Trends
  4. Asia-Pacific Anxiety Disorders and Depression Treatment Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Product Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • MAOIs (Monoamine Oxidase inhibitors)
      • Atypical Antipsychotics
      • Benzodiazepines
      • Anticonvulsants
      • Beta-Blockers
      • SRIs (Selective Serotonin Reuptake Inhibitors)
      • SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)
      • TeCAs (Tetracyclic Antidepressants)
      • TCAs (Tricyclic Antidepressants)
      • Others
    • Distribution Channel Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Online Pharmacies
      • Others
    • Country Analysis2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Anxiety Disorders and Depression Treatment Market – Opportunity Analysis Index, By Product Type, By Distribution Channel, and Country,2020 – 2026
    • Asia-Pacific Anxiety Disorders and Depression Treatment Market Dynamics – Trends
  5. Latin America Anxiety Disorders and Depression Treatment Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Product Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • MAOIs (Monoamine Oxidase inhibitors)
      • Atypical Antipsychotics
      • Benzodiazepines
      • Anticonvulsants
      • Beta-Blockers
      • SRIs (Selective Serotonin Reuptake Inhibitors)
      • SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)
      • TeCAs (Tetracyclic Antidepressants)
      • TCAs (Tricyclic Antidepressants)
      • Others
    • Distribution Channel Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Online Pharmacies
      • Others
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Anxiety Disorders and Depression Treatment Market – Opportunity Analysis Index, By Product Type, By Distribution Channel, and Country,2020 – 2026
    • Latin America Anxiety Disorders and Depression Treatment Market Dynamics – Trends
  6. Middle East and Africa Anxiety Disorders and Depression Treatment Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Product Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • MAOIs (Monoamine Oxidase inhibitors)
      • Atypical Antipsychotics
      • Benzodiazepines
      • Anticonvulsants
      • Beta-Blockers
      • SRIs (Selective Serotonin Reuptake Inhibitors)
      • SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)
      • TeCAs (Tetracyclic Antidepressants)
      • TCAs (Tricyclic Antidepressants)
      • Others
    • Distribution Channel Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Online Pharmacies
      • Others
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Anxiety Disorders and Depression Treatment Market – Opportunity Analysis Index, By Product Type, By Distribution Channel, and Country,2020 – 2026
    • MEA Anxiety Disorders and Depression Treatment Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Product Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Eli Lilly and Company (U.S)
      • Lundbeck A/S (Denmark)
      • AstraZeneca (UK)
      • Merck and Company, Inc. (U.S)
      • Johnson and Johnson (U.S)
      • Sanofi-Aventis (France)
      • GlaxoSmithKline plc (UK)
      • Pfizer, Inc. (U.S)
  1. Research Methodology
  2. Key Assumptions and Acronyms

 

  1. Disclaimer
  2. The above mentioned segmentation is tentative; it is changed according to client’s requirement, or research feasibility.

Report

Company Profile

  • Eli Lilly and Company (U.S)
  • Lundbeck A/S (Denmark)
  • AstraZeneca (UK)
  • Merck and Company, Inc. (U.S)
  • Johnson and Johnson (U.S)
  • Sanofi-Aventis (France)
  • GlaxoSmithKline plc (UK)
  • Pfizer, Inc. (U.S)

Description

The global Anxiety Disorders and Depression Treatment Market size was estimated at USD 8.2 Bn in 2021, growing at a CAGR of 27.8% during the forecast period 2021-2027. Anxiety is a disorder that differs from normal feelings of nervousness or anxiousness. It involves excessive anxiety. Anxiety is a normal reaction to stress. For a patient with anxiety disorder, the anxiety does not lessen but can get worse over a period of time. As per the American Psychiatric Association, Anxiety disorders are the most common of mental disorders and affect nearly 30 percent of adults at some point in their lives. The feelings can interfere with daily activities. There are various kinds of anxiety disorders such as social anxiety disorder and panic disorder. The Anxiety Disorders and Depression Treatment Market research report covers exhaustive regional information, that includes North America (the USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland, and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentian, Venezuela, and Rest of Latin America), and the Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of the Middle East and Africa).

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX